Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice
  2. Hamilton, Betty K; Cutler, Corey; Divine, Clint; Juckett, Mark; LeMaistre, Charles; Stewart, Susan; Wilder, Jennifer; Horowitz, Mary; Khera, Nandita; Burns, Linda J
  3. Transplantation and Cellular Therapy. 2022, May 09;
  1. 2.   Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
  2. Parta,Mark; Hilligoss, Dianne; Kelly, Corin; Kwatemaa, Nana; Theobald, Narda; Zerbe, Christa S; Holland, Steven M; Malech, Harry L; Kang, Elizabeth M
  3. Journal of clinical immunology. 2020, Apr 20;
  1. 3.   The MHC in the era of next-generation sequencing: Implications for bridging structure with function
  2. Petersdorf, Effie W.; Ohuigin,Colm
  3. HUMAN IMMUNOLOGY. 2019, Jan; 80(1): 67-78.
  1. 4.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 5.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 6.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 7.   Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation
  2. Petersen, S. L.; Sidorov, I. A.; Russell, C. A.; Dickmeiss, E.; Vindelov, L. L.
  3. Transplantation. 2005, SEP 15; 80(5): 573-581.
  1. 8.   Differential response of murine CD4(+)CD25(+) and CD4(+)CD25(-) T cells to dexamethasone-induced cell death
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, D. M. Z.
  3. European Journal of Immunology. 2004 34(3): 859-869.
  1. 9.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 10.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 11.   PS-341 administration inhibits acute graft-versus-host disease and preserves graft-versus-tumor after allogeneic BMT in advanced tumor-bearing mice
  2. Sun, K.; Welniak, L. A.; Wilkins, D.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Blood. 2003 102(11, Part 1): 192A-192A.
  1. 12.   Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation
  2. Hixon, J. A.; Blazar, B. R.; Anver, M. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2001 7(3): 136-143.
  1. 13.   Renal transplant patients show variations in their self- reactive repertoires: a serial study
  2. Portugal, K.; Dozmorov, I.; Sidorov, I.; Marrero, I.; Fonseca, J. A.; Spadafora-Ferreira, M.; Kalil, J.; Coelho, V.
  3. International Immunology. 2001 13(6): 747-755.
  1. 14.   Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development
  2. Faries, M. B.; Bedrosian, I.; Xu, S. W.; Koski, G.; Roros, J. G.; Moise, M. A.; Nguyen, H. Q.; Engels, F. H. C.; Cohen, P. A.; Czerniecki, B. J.
  3. Blood. 2001 98(8): 2489-2497.
  1. 15.   Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies
  2. Murphy, W. J.; Koh, C. Y.; Raziuddin, A.; Bennett, M.; Longo, D. L.
  3. Immunological Reviews. 2001 181: 279-289.
  1. 16.   Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation
  2. Panoskaltsis-Mortari, A.; Strieter, R. M.; Hermanson, J. R.; Fegeding, K. V.; Murphy, W. J.; Farrell, C. L.; Lacey, D. L.; Blazar, B. R.
  3. Blood. 2000 96(3): 834-839.
  1. 17.   Adoptive cellular immunotherapy: NK cells and bone marrow transplantation
  2. Koh, C. Y.; Welniak, L. A.; Murphy, W. J.
  3. Histology and Histopathology. 2000 15(4): 1201-1210.
  1. 18.   Induction of CD4(+) T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta(1)
  2. Zeller, J. C.; Panoskaltsis-Mortari, A.; Murphy, W. J.; Ruscetti, F. W.; Narula, S.; Roncarolo, M. G.; Blazar, B. R.
  3. Journal of Immunology. 1999 163(7): 3684-3691.
  1. 19.   Suppression of Graft-Versus-Host Disease and Amplification of Graft-Versus-Tumor Effects By Activated Natural Killer Cells After Allogeneic Bone Marrow Transplantation
  2. Asai, O.; Longo, D. L.; Tian, Z. G.; Hornung, R. L.; Taub, D. D.; Ruscetti, F. W.; Murphy, W. J.
  3. Journal of Clinical Investigation. 1998 101(9): 1835-1842.
  1. 20.   Differential Effects of the Absence of Interferon-Gamma and Il-4 in Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice
  2. Murphy, W. J.; Welniak, L. A.; Taub, D. D.; Wiltrout, R. H.; Taylor, P. A.; Vallera, D. A.; Kopf, M.; Young, H.; Longo, D. L.; Blazar, B. R.
  3. Journal of Clinical Investigation. 1998 102(9): 1742-1748.
  1. 21.   In Vivo Alloreactive Potential of Ex Vivo Expanded Primary T Lymphocytes
  2. Contassot, E.; Murphy, W.; Angonin, R.; Pavy, J. J.; Bittencourt, M. C.; Robinet, R.; Reynolds, C. W.; Cahn, J. Y.; Herve, P.; Tiberghien, P.
  3. Transplantation. 1998 65(10): 1365-1370.
  1. 22.   Thymidine Kinase (Tk) Gene-Transduced Human Lymphocytes Can Be Highly Purified, Remain Fully Functional, and Are Killed Efficiently With Ganciclovir
  2. Munshi, N. C.; Govindarajan, R.; Drake, R.; Ding, L. M.; Iyer, R.; Saylors, R.; Kornbluth, J.; Marcus, S.; Chiang, Y.; Ennist, D.; Kwak, L.; Reynolds, C.; Tricot, G.; Barlogie, B.
  3. Blood. 1997 89(4): 1334-1340.
  1. 23.   Use of Donor T-Lymphocytes Expressing Herpes-Simplex Thymidine Kinase in Allogeneic Bone Marrow Transplantation - a Phase I-Ii Study
  2. Tiberghien, P.; Cahn, J. Y.; Brion, A.; Deconinck, E.; Racadot, E.; Herve, P.; Milpied, N.; Lioure, B.; Gluckman, E.; Bordigoni, P.; Jacob, W.; Chiang, Y. W.; Marcus, S.; Reynolds, C.; Longo, D.
  3. Human Gene Therapy. 1997 8(5): 615-624.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel